Teva Pharmaceutical Industries (TEVA) FCF Payout Ratio (2009 - 2018)

Teva Pharmaceutical Industries (TEVA) has reported FCF Payout Ratio for 10 consecutive years, with 0.01 the latest figure, recorded in Q1 2018.

• Quarterly FCF Payout Ratio rose 100.17% year-over-year to 0.01 in Q1 2018, while the trailing twelve-month figure through Dec 2018 was 0.01 (down 99.0% YoY) and the FY2018 annual result came in at 0.01, down 99.0% from the prior year.
• FCF Payout Ratio eased to 0.01 in Q1 2018 per TEVA's latest filing, from 0.15 in the prior quarter.
• Over the last five years, FCF Payout Ratio for TEVA reached as high as 1.43 in Q2 2017 and fell as low as 5.24 in Q1 2017.
• A 5-year average of 0.1 and a median of 0.24 in 2014 frame the typical range for FCF Payout Ratio.
• The largest YoY upside for FCF Payout Ratio was 262.38% in 2017 against a maximum downside of 2155.99% in 2017.
• Year by year, FCF Payout Ratio stood at 0.19 in 2014, then increased by 13.25% to 0.21 in 2015, then plunged by 771.18% to 1.42 in 2016, then soared by 110.32% to 0.15 in 2017, then tumbled by 93.87% to 0.01 in 2018.
• According to Business Quant data, FCF Payout Ratio over the past three periods registered 0.01, 0.15, and 0.21 for Q1 2018, Q4 2017, and Q3 2017 respectively.